WO2002032395A3 - Sustained release delivery system and uses thereof - Google Patents

Sustained release delivery system and uses thereof Download PDF

Info

Publication number
WO2002032395A3
WO2002032395A3 PCT/IL2001/000966 IL0100966W WO0232395A3 WO 2002032395 A3 WO2002032395 A3 WO 2002032395A3 IL 0100966 W IL0100966 W IL 0100966W WO 0232395 A3 WO0232395 A3 WO 0232395A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery system
sustained release
release delivery
bicellar
matrix
Prior art date
Application number
PCT/IL2001/000966
Other languages
French (fr)
Other versions
WO2002032395A2 (en
Inventor
Frederic Amnon Kestel
Original Assignee
Advanced Delivery Systems Aps
Frederic Amnon Kestel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Delivery Systems Aps, Frederic Amnon Kestel filed Critical Advanced Delivery Systems Aps
Priority to AU2002210894A priority Critical patent/AU2002210894A1/en
Publication of WO2002032395A2 publication Critical patent/WO2002032395A2/en
Publication of WO2002032395A3 publication Critical patent/WO2002032395A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a sustained release delivery system for the delivery of an active agent to a warm-blooded animal and to uses thereof. The delivery system comprises an aqueous bicellar matrix that is liquid at temperatures below ambient temperature and forms a biodegradable gel at body temperature of said animal and an active agent, and optionally further comprises pharmaceutically acceptable additive, carrier and/or diluent. The aqueous bicellar matrix is preferably a mixture of a lipid, preferably phospholipid, and a detergent in water.
PCT/IL2001/000966 2000-10-20 2001-10-18 Sustained release delivery system and uses thereof WO2002032395A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002210894A AU2002210894A1 (en) 2000-10-20 2001-10-18 Sustained release delivery system and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13917700A IL139177A0 (en) 2000-10-20 2000-10-20 Sustained release drug delivery system
IL139177 2000-10-20

Publications (2)

Publication Number Publication Date
WO2002032395A2 WO2002032395A2 (en) 2002-04-25
WO2002032395A3 true WO2002032395A3 (en) 2002-12-19

Family

ID=11074743

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2001/000966 WO2002032395A2 (en) 2000-10-20 2001-10-18 Sustained release delivery system and uses thereof

Country Status (3)

Country Link
AU (1) AU2002210894A1 (en)
IL (1) IL139177A0 (en)
WO (1) WO2002032395A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007014068A (en) * 2005-05-10 2008-02-07 Novartis Ag Modified release famciclovir pharmaceutical compositions.
CN101505768B (en) 2006-06-23 2013-11-06 因詹尼克分子递送控股有限公司 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
ES2364771B1 (en) * 2010-03-01 2013-01-29 Consejo Superior De Investigaciones Científicas (Csic) BICELAS ENCAPSULADAS IN LIPOSOMAS AND ITS APPLICATION IN DILUIDED SYSTEMS.
AU2010359346B2 (en) 2010-08-20 2015-01-29 Dr. Reddy's Laboratories Sa Phospholipid depot
MX354575B (en) 2010-10-22 2018-03-12 Dr Reddys Laboratories Inc Use of storage stable viscous phospholipid depot to treat wounds.
RU2678433C2 (en) 2012-05-10 2019-01-29 Пейнреформ Лтд. Depot formulations of hydrophobic active ingredient and methods for preparation thereof
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9956164B2 (en) 2014-04-16 2018-05-01 Veyx-Pharma Gmbh Veterinary pharmaceutical composition and use thereof
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475160A1 (en) * 1990-08-24 1992-03-18 Gregor Prof. Dr. Cevc Preparation for drug application in minute droplet form
EP0730860A2 (en) * 1995-03-07 1996-09-11 F. Hoffmann-La Roche Ag Mixed micelles

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475160A1 (en) * 1990-08-24 1992-03-18 Gregor Prof. Dr. Cevc Preparation for drug application in minute droplet form
EP0730860A2 (en) * 1995-03-07 1996-09-11 F. Hoffmann-La Roche Ag Mixed micelles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRANK RINALDI; ET AL.: "Delta-Opiate DPDPE in Magnetically Oriented Phospholipid Micelles: Binding and Arrangement of Aromatic Pharmacophores", BIOPHYSICAL JOURNAL, vol. 73, no. 6, December 1997 (1997-12-01), pages 3337 - 3348, XP008008942 *

Also Published As

Publication number Publication date
IL139177A0 (en) 2001-11-25
WO2002032395A2 (en) 2002-04-25
AU2002210894A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
WO2002032395A3 (en) Sustained release delivery system and uses thereof
BR0014504A (en) Water unstable foam
ATE238813T1 (en) SUSTAINED RELEASE ACTIVE FORMULATIONS
PT850046E (en) MICROEMULATIONS FOR USE AS VEHICLES FOR ADMINISTRATION OF ACTIVE COMPOUNDS
EP1357870A4 (en) Bioadhesive cell foam film of sustained-release delivery
EP1139753A4 (en) Formulations for treating disease and methods of using same
CA2333869A1 (en) Mousse composition
WO2003030818A3 (en) Active agents using liposome beads
BR0015567A (en) Phenoxycarboxylic acid compounds and compositions for releasing active agents
EP1286662A4 (en) Tablets and methods for modified release of hydrophilic and other active agents
WO2008007224A3 (en) Foamable suspension gel
BRPI0412975A (en) penetrating foam for pharmaceutical use
WO2001060335A3 (en) Delivery systems using preformed biodegradable polymer compositions and methods
WO2007050543A3 (en) Topical pharmaceutical foam composition
DK0695172T3 (en) Fast-release solid preparation, its preparation and its use
DE60138468D1 (en) CYANOPHENOXY CARBOXYLIC ACIDS AND COMPOSITIONS FOR THE RELEASE OF ACTIVE SUBSTANCES
WO2003022252A3 (en) Combinatorial type (several vehicles within a housing) controlled release drug delivery device
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
BR0007360A (en) Controlled release composition
WO2002055098A3 (en) Latency associated peptide for providing latency to pharmaceutically active proteins
HK1040920A1 (en) Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent.
NO20024155L (en) Process for the preparation of phosphorothioate esters
NZ505088A (en) Aqueous insecticidal pour-on formulation; comprising insect growth regulator (IGR), surfactant, suspending agent and aqueous carrier
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
BR0014530A (en) Foams and compositions containing these foams

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP